The effect of 12 weeks of aerobic exercise training with or without saffron supplementation on diabetes-specific markers and inflammation in women with type 2 diabetes: A randomized double-blind placebo-controlled trial.

Ali Rajabi, Ali Akbar Nezhad Gharehlo, Elham Madadizadeh, Aref Basereh, Kimya Khoramipoor, Hossein Pirani, Karen Khoramipour, Othmar Moser, Kayvan Khoramipour

Journal: European journal of sport science 2024;24(7):899-906

PMID: 38874882

Plain Language Summary

plain language summary logo

Individuals with type 2 diabetes (T2D) face an 80% higher mortality rate due to cardiovascular disease. Given the rising prevalence of T2D and its associated complications, exploring non-pharmacological interventions is crucial. The primary aim was to evaluate whether 12 weeks of aerobic exercise, with or without saffron supplementation, could improve diabetes-specific markers and reduce inflammation in women with T2D. This study was a randomised, double-blind, placebo-controlled trial. Participants were randomly assigned to one of four groups: aerobic exercise with saffron supplementation, aerobic exercise with placebo, saffron supplementation alone, or placebo alone. Results showed that 12 weeks of aerobic exercise, especially when combined with saffron supplementation, significantly improves diabetes-specific markers and reduces inflammation in women with T2D. Authors concluded that their findings suggest that incorporating aerobic exercise and saffron into the management plan for T2D could be beneficial.

Abstract

This study was conducted to investigate the effects of 12 weeks of aerobic exercise (AT) and saffron supplementation on hemostasis, inflammatory markers, and insulin resistance in obese women diagnosed with type 2 diabetes (T2D). A total of 44 women with T2D (mean age: 54.12 ± 5.63 years, mean BMI: 31.15 ± 1.50 kg/m, HbA1c: 85 ± 4.2 mmol/mol) were included in a randomized, double-blind, placebo-controlled study. We were randomly assigned to one of four groups (n = 11 per group): saffron + training (ST), placebo + training (PT), saffron supplement (SS), and placebo (P). The ST and PT groups completed 12 weeks of AT (three sessions per week of mild to moderate intensity). The ST and SS groups were administered a daily dose of 200 mg of saffron powder for 12 weeks. Fasting blood samples were collected 48 h before the first AT session and/or nutritional supplementation and 48 h after the last AT session and/or nutritional supplementation. Post-evaluation, homeostatic model assessment of insulin resistance value (HOMA-IR, p < 0.001) and serum levels of glucose (p < 0.001), fibrinogen (FIB, p < 0.001), homocysteine (HCY, p < 0.001), interleukin-6 (IL-6, p < 0.001), and tumor necrosis factor α (TNFα, p < 0.001) showed significant reduction in the ST, PT, and SS groups compared to the P group (p < 0.05). In particular, the ST group showed a more significant reduction in all variables compared to the PT and SS groups (p < 0.05). Our results suggest that a 12-week intervention with AT and saffron supplementation can independently improve markers related to hemostasis, inflammation, and insulin resistance. However, their combination showed the greatest effectiveness on the above markers.

© 2024 The Author(s). European Journal of Sport Science published by Wiley‐VCH GmbH on behalf of European College of Sport Science.

Address: Faculty of Educational Sciences and Psychology, Department of Exercise Physiology, University of Mohaghegh Ardabili, Ardabil, Iran.; Faculty of Physical Education and Sport Sciences, Department of Exercise Physiology, University of Tehran, Tehran, Iran.; Faculty of Physical Education, Department of Exercise Physiology, Shahid Bahonar University, Kerman, Iran.; Department Exercise Physiology, Kharazmi University, Tehran, Iran.; Faculty of Nursing and Midwifery, Department of Nursing, Kurdistan University of Medical Sciences, Kurdistan, Iran.; Faculty of Marine Sciences, Department of Science, Maritim University of Chabahar, Chabahar, Iran.; Faculty of Humanities and Social Sciences, Department of Sport Science, Kurdistan University, Kurdistan, Iran.; Exercise Physiology and Metabolism (Sports Medicine), BaySpo-Bayreuth Centre of Sports Science, University of Bayreuth, Bayreuth, Germany.; Interdisciplinary Metabolic Medicine Trials Unit, Medical University of Graz, Graz, Austria.; Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran.

Laboratory Testing

Modifiable Lifestyle Factors

Jadad Score

Allocation Concealment

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.